FDA Reconsiders Previously Rejected Treatment for Rare Cancer
The FDA is revisiting a rare cancer treatment it had turned down earlier this year, amidst discussions on drug pricing and advancements in biotech.
Editorial Staff May 7
Health
Latest Health stories from Life.
OpenAI Proposes Health Policy Changes Amid Dexcom CGM Developments
OpenAI has released a health policy blueprint while Dexcom updates its continuous glucose monitoring technology, alongside concerns regarding whole body scans.
Editorial Staff May 7
FDA to Reassess Ebvallo After Unexpected Rejection
Following a surprising rejection, the FDA will revisit the treatment for a rare cancer, as the developers of Ebvallo have reached an agreement to tackle the concerns raised.
Editorial Staff May 7
Rising Trend of Hospital Shootings Since 2000 Raises Concerns
A recent report indicates a steady increase in hospital shootings since 2000, highlighting a troubling trend in healthcare safety and security.
Editorial Staff May 7
Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion
In a significant move within the pharmaceutical industry, Angelini Pharma has announced its acquisition of Catalyst Pharmaceuticals, a company specializing in treatments for rare diseases, for $4.1 billion.
Editorial Staff May 7
Concerns Raised Over Hantavirus Research Amid Cruise Ship Outbreak
Public health experts express alarm not over the MV Hondius cruise ship as a pandemic threat, but due to insufficient research on hantaviruses.
Editorial Staff May 7
PeaceHealth Abandons Plan to Outsource Emergency Staffing Amid Local Backlash
In response to significant local opposition and potential legal challenges, PeaceHealth has decided not to proceed with its plan to replace Eugene Emergency Physicians with ApolloMD.
Editorial Staff May 6
Contradictions in Trump Administration's Drug Policy Raise Concerns
The Trump administration's recent actions regarding drug policy appear inconsistent, as the White House endorses treatment methods while imposing new restrictions.
Editorial Staff May 6
The Case for 'Most Favored Nation' Drug Pricing: A Timely Discussion
As discussions around pharmaceutical pricing evolve, the 'Most Favored Nation' model emerges as a potential solution worth considering for its implications and benefits.
Editorial Staff May 6
Sanofi Seeks FDA Withdrawal of Diabetes Drug from Fast-Track Review Amid Political Concerns
In a notable move, Sanofi has requested the FDA to withdraw its type 1 diabetes drug from the expedited review process, citing political interference as a key factor.
Editorial Staff May 6
Color Health Ventures into Cancer Care with New Virtual Tumor Boards
Color Health is broadening its services to include cancer care coordination, aiming to fill a significant void in the healthcare landscape.
Editorial Staff May 6
FDA's Decision on Fruit-Flavored Vapes Sparks Debate
Marty Makary shares his initial doubts regarding flavored vapes but points to the potential of age-gating technology to mitigate risks.
Editorial Staff May 6
Global Initiative Reveals Mini-Proteins That Could Transform Understanding of Diseases
A collaborative effort by researchers worldwide has uncovered thousands of mini-proteins, some linked to critical processes like cell division and DNA repair, with implications for cancer research.
Editorial Staff May 6
Current Landscape of Medicaid Expansion Decisions Across States
An overview of the ongoing decisions regarding Medicaid expansion in various states under the Affordable Care Act, highlighting the latest developments.
Editorial Staff May 6
Evolving Conversations on Health AI: A Shift in Perspective
Brittany Trang highlights a potential shift in the dialogue surrounding AI in health care, suggesting that discussions may be moving beyond initial hype.
Editorial Staff May 6
Novo Nordisk Sees Positive Impact from Wegovy Pill Update on Earnings and Stock
Recent developments regarding Novo Nordisk's Wegovy pill have led to an uptick in the company's earnings and share price, alongside other notable biotech news.
Editorial Staff May 6
PhRMA Initiates Advertising Campaign Against 340B Drug Discount Program
The Pharmaceutical Research and Manufacturers of America (PhRMA) has launched a substantial ad campaign aimed at the 340B drug discount program, highlighting its budget and focus.
Editorial Staff May 6
Supreme Court to Hear Louisiana's Challenge on Mifepristone Access
The Supreme Court is set to review Louisiana's challenge against the FDA regarding mifepristone, a case that underscores the contentious legal landscape surrounding abortion rights in the U.S.
Editorial Staff May 6
Examining Consumer Protections for AI in Healthcare Claims Review
As artificial intelligence becomes increasingly integrated into healthcare claims processes, this discussion highlights the importance of consumer protections at both federal and state levels.
Editorial Staff May 6
KFF Launches Interactive Dashboard on Health Information Trust
KFF has unveiled an interactive dashboard that monitors public trust in health information sources and explores attitudes toward vaccines, reflecting current trends.
Editorial Staff May 6